missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ RBP4 Monoclonal Antibody (4C2)
Description
MA5-15838 targets RBP4 in indirect ELISA, FACS, IF, IHC, and WB applications and shows reactivity with Human samples. The MA5-15838 immunogen is purified recombinant fragment of human RBP expressed in E. Coli. MA5-15838 detects RBP4 which has a predicted molecular weight of approximately 23kDa.
This protein belongs to the lipocalin family and is the specific carrier for retinol in the blood. It delivers retinol from the liver stores to the peripheral tissues. In plasma, the RBP-retinol complex interacts with transthyretin which prevents its loss by filtration through the kidney glomeruli. A deficiency of vitamin A blocks secretion of the binding protein post translationally and results in defective delivery and supply to the epidermal cells.
Specifications
Specifications
| Antigen | RBP4 |
| Applications | ELISA, Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Monoclonal |
| Clone | 4C2 |
| Concentration | Conc. Not Determined |
| Conjugate | Unconjugated |
| Formulation | Ascites with 0.03% sodium azide |
| Gene | RBP4 |
| Gene Accession No. | P02753 |
| Gene Alias | MCOPCB10; Plasma retinol binding protein 4 (PRBP); Plasma retinol-binding protein; Plasma retinol-binding protein(1-176); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-182); PRBP; PRO2222; RBP; Rbp4; Rbp-4; RBPA; RDCCAS; retinol; retinol binding; retinol binding protein 4; Retinol binding protein 4 interstitial; retinol binding protein 4, cellular; retinol binding protein 4, plasma; retinol-binding protein 4; retinol-binding protein 4, interstitial |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?